Treatments Sample Clauses

Treatments. A. Properties identified in the inventory as being individually rated Outstanding or Notable, rated Contributing to an identified district or properties that are individually listed or contributing to a listed district, or properties determined to be eligible for inclusion in the National Register by both the City and the Indiana SHPO shall be rehabilitated in accordance with the recommended approaches in the Secretary of the Interior’s Standards for the Treatment of Historic Properties; Guidelines for Rehabilitation of Historic Buildings (Standards and Guidelines for Rehabilitation; National Park Service, 1995; 36 CFR Section 67.7). 1. To ensure conformance with the Standards and Guidelines for Rehabilitation, rehabilitation plans shall be reviewed by a professional, as defined in I, above, before construction begins. 2. When conformance with the Standards and Guidelines for Rehabilitation is ensured, the City shall document that the project will have no adverse effect on historic properties within the project APE and retain documentation in individual project files. 3. The City shall document the property, including photographs, work write-ups/journal, professional review, etc. before work begins and upon completion of the rehabilitation to evidence adherence to the Standards and Guidelines for Rehabilitation. The City shall retain documentation in individual project files. B. When it is determined that a project cannot adhere to the Standards and Guidelines for Rehabilitation or when demolition or relocation of, or any other adverse effect as defined in 36 CFR Part 800.5(a) on a property that meets the National Register criteria is proposed, the City shall apply the Criteria of Adverse Effect. Upon the City’s conclusion of a Finding of Adverse Effect, or if there is any question as to whether a property may meet the Criteria of Adverse Effect, the City shall consult with the Indiana XXXX. 0. If the Criteria of Adverse Effect are met, the City will determine if project activities can be modified to avoid adverse effects. If adverse effects can be avoided through project modification, the City will document that the project will have no adverse effect on historic properties and retain documentation in individual project files. a. If adverse effects cannot be avoided through project modification, the City will prepare documentation for individual submission to the Indiana SHPO that includes all project information and any mitigation proposals, requesting c...

Treatments. There are Standards for four distinct, but interrelated, approaches to the treatment of historic properties -- Preservation, Rehabilitation, Restoration, and Reconstruction. Preservation focuses on the maintenance and repair of existing historic materials and retention of a property’s form as it has evolved over time. (Protection and Stabilization have now been consolidated under this treatment.) Rehabilitation acknowledges the need to alter or add to a historic property to meet continuing or changing uses while retaining the property’s historic character. Restoration is undertaken to depict a property at a particular period of time in its history, while removing evidence of other periods. Reconstruction re-creates vanished or non-surviving portions of a property for interpretive purposes. In summary, the simplification and sharpened focus of these revised sets of treatment standards is intended to assist users in making sound historic preservation decisions. Choosing appropriate treatment for a historic property, whether preservation, rehabilitation, restoration, or reconstruction, is critical. This choice always depends on a variety of factors, including the property’s historical significance, physical condition, proposed use, and intended interpretation.

Treatments. All signs, decorations, advertising media, blinds, draperies and other window treatment or bars or other security installations visible from outside the Premises shall be subject to Landlord's approval and conform in all respects to Landlord's requirements. Tenant may, at its sole cost and expense, place its name on the two (2) existing monument signs as more fully described on Exhibit A, subject to Landlord's prior approval of Tenant's plans and specifications related to such signage and subject to Landlord's standard sign specifications for the Project.

Treatments. 3.4.1 The exterior design and materials of the building shall be as generally shown on Schedules D, E, and F. 3.4.2 Each building material, as shown on the Schedules, shall be a distinct tone or colour. 3.4.3 All vents, down spouts, flashing, electrical conduits, meters, service connections, and other functional elements shall be treated as integral parts of the design. 3.4.4 The building shall be designed such that the mechanical systems (HVAC, exhaust fans, vents etc.) shall be located on the rooftop and are not visible from all abutting streets and abutting properties. This requirement shall exclude individual residential mechanical systems. 3.4.5 Fixed or retractable awnings and canopies are permitted at the ground floor level, provided that the awnings and canopies are designed as an integral part of the building façade. 3.4.6 All roof mounted mechanical or telecommunication equipment shall be visually integrated into the roof design or screened so that they are not visible from all adjacent streets or properties. 3.4.7 All exposed concrete surfaces shall be architecturally textured. Any exposed foundation in excess of two (2) feet in height shall be architecturally detailed. 3.4.8 There shall be no outdoor storage, other than outdoor storage for individual residential units, on the Lands. 3.4.9 Each commercial occupancy shall have its own entrance from Oxford Street. A minimum of two commercial entrances shall be provided along the commercial façade.

Treatments. 1. Each Contracting Party shall in its territory accord investments of the investors of the other Contracting Party treatment no be less favorable than that it accords to investments made by it own investor or investors of any third states in like circumstances, which ever is the more favorable. 2. Each Contracting Party shall in its territory accord investors of the other Contracting Party, as regards their management, maintenance, use, enjoyment of their investments, treatment no less favorable than that it accords to investments made by it own investor or investors of any third states, which ever is the more favorable.

Treatments. As far as Pixar develops treatments based on an original idea from Pixar, an idea adopted by Pixar or an idea of the public domain (but not an original idea material assigned by Disney to Pixar, which will be disney's property or material) rejected by Disney in accordance with the procedure laid down in paragraph 3 above, [*] [*] will be [*] in and to such treatments [*] [*] [*] in and to such treatments. Pixar will the right to [*] Certain information on this page has been omitted and

Treatments. For each of the four remaining Pictures, Pixar shall submit one or more Treatments for Disney's consideration as the basis for the Picture ("Treatment"). Each Treatment shall be either (a) a written treatment of not less than three pages in length setting forth a story to be used as the basis for the screenplay or (b) an oral presentation of not more than one (1) hour, accompanied by rough sketches, conceptual art and rudimentary story boards sufficient to communicate the essential idea for the Picture comparable to the presentation previously made for Bugs and the first presentation for the second Picture. Each such Treatment shall be based on a new idea and not be a sequel, prequel or remake of a prior picture. Treatments may be submitted by Pixar singly or in one or more groups. Disney shall accept or reject each Treatment within forty-five (45) days after such Treatment -1- 6 is submitted by Pixar. [*] for [*] of the [*] within [*] by [*] of the [*], then [*], whether or not it [*], to [*], by giving written notice of [*] at any time [*] unless [*] the parties have [*] or [*] this Agreement under the provisions of subparagraph (ii) below: (A) [*] of the [*] as the [*] for a [*], provided in the event of [*] under this subparagraph A the [*] to [*] and [*] shall be [*] (unless [*] to [*] and with the [*] specified in [*], or (B) in the case of [*] of the [*] as the [*] for such [*] and in the event of [*] under this subparagraph B [*] and [*] shall be [*] (unless [*] to [*]) and with the [*] specified in [*].

Treatments. The costs of whole blood, blood plasma or specialized treatments using radium and radioisotopes are covered, when rendered due to emergency hospitalization.

Treatments. To the extent Pixar develops any Treatments based on a Pixar original idea, an idea acquired by Pixar or a public domain idea (but not an original idea or material assigned by Disney to Pixar, which idea or material shall be owned by Disney) which were rejected by Disney pursuant to the procedure set forth in paragraph 3 above, [*] shall [*] all [*] in and to such Treatments. Pixar shall have the right to ------- [*] Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions. -22- 27 continue to develop and use such Treatments subject to the provisions of paragraph 17(a) below, provided that for any Treatment which Pixar uses as the basis for a motion picture, Pixar shall reimburse Disney upon commencement of production animation for the amount paid by Disney for such Treatment, with interest at the Bank of America reference rate plus 125 basis points from the date of Disney's payment. Nothing in this provision shall be deemed to place either party in a worse position with respect to use of public domain ideas and public domain materials than a member of the general public. 14.

Treatments. The only treatment approved for any form of NCL is cerliponase alfa, an enzyme replacement therapy (ERT) for CLN2 disease (FDA, 2017; Xxxxxx et al., 2018). Unfortunately ERT is not an option for transmembrane protein-deficient NCLs, including CLN3 and CLN7, as ERT relies on the principle of cross-correction (Xxxxxxxx et al., 2015). Similarly, cell-based therapies, such as stem cell transplantation or bone marrow transplantation are not appropriate for the transmembrane protein-deficient forms of NCL either, as they equally rely on cross- correction (Xxxxxxx et al., 2015; Xxxxx, 2017; Xxxx et al., 2019). Supplying neuronal stem cells to the brain to replace lost neurons has been shown to be not feasible, with the majority of cells grafted into Cln1 disease mice staying in a relatively undifferentiated state (Xxxxxx et al., 2009). As such, the following part of the introduction will focus mainly on treatment approaches that have shown at least some success or promise in the treatment of transmembrane protein deficient forms of NCL.